The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival analysis by tumor response from real-world data in advanced gastric cancer treated with nivolumab: The DELIVER trial (JACCRO GC-08).
 
Yosuke Kito
Honoraria - Chugai Pharma; Merck; Taiho Pharmaceutical; Takeda
 
Eisuke Inoue
Consulting or Advisory Role - Nippon Tect Systems; Pfizer
Speakers' Bureau - Bristol-Myers Squibb Japan
 
Yusuke Akamaru
No Relationships to Disclose
 
Masazumi Takahashi
No Relationships to Disclose
 
Jin Matsuyama
No Relationships to Disclose
 
Hiroshi Yabusaki
No Relationships to Disclose
 
Akitaka Makiyama
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Lilly Japan
 
Takahisa Suzuki
No Relationships to Disclose
 
Masahiro Tsuda
No Relationships to Disclose
 
Hisateru Yasui
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Lilly; Merck; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; TERUMO; Yakult Honsha
Research Funding - Astellas Pharma (Inst); Daiichi Sankyo (Inst); MSD (Inst); Ono Pharmaceutical (Inst)
 
Naoki Hirabayashi
No Relationships to Disclose
 
Atsushi Takeno
No Relationships to Disclose
 
Hisato Kawakami
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb Japan; Chugai/Roche; Daiichi Sankyo; Lilly Japan; Merck Serono; MSD K.K; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Consulting or Advisory Role - Bristol-Myers Squibb Japan; Daiichi Sankyo Co. Ltd.,; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst)
 
Hiroyuki Okuda
No Relationships to Disclose
 
Takashi Yoshioka
No Relationships to Disclose
 
Junji Kawada
No Relationships to Disclose
 
Yasuhiro Kodera
Honoraria - Chugai Pharma; Covidien/Medtronic; Daiichi Sankyo; Intuitive Surgical; Johnson & Johnson; Kaken Pharmaceutical; Lilly; MSD K.K; Nippon Kayaku; Ono Pharmaceutical; Otsuka; Taiho Pharmaceutical; Tsumura & Co.; Yakult Honsha
Research Funding - abbott Japan (Inst); Chugai Pharma (Inst); Covidien (Inst); Daiichi Sankyo (Inst); EA Pharma (Inst); Kaken Pharmaceutical (Inst); Lilly Japan (Inst); Maruho (Inst); MSD (Inst); Nippon Kayaku (Inst); Ono Pharmaceutical (Inst); Otsuka (Inst); Otsuka (Inst); Pfizer (Inst); Sanofi (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Tsumura & Co. (Inst); Yakult Pharmaceutical (Inst)
 
Wataru Ichikawa
Honoraria - Bayer Yakuhin; Chugai Pharma; Daiichi Sankyo; Lilly Japan; Merck Serono; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Daiichi Sankyo
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo; Merck Serono (Inst); Ono Pharmaceutical (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Masashi Fujii
Travel, Accommodations, Expenses - Japan Clinical Cancer Research Organization; Taiho Pharmaceutical
 
Yu Sunakawa
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Kyowa Hakko Kirin; Lilly Japan; Merck; MSD K.K; Nippon Kayaku; Sanofi; Sysmex; Taiho Pharmaceutical; Takeda; Yakult Honsha
Consulting or Advisory Role - Bristol-Myers Squibb Japan; MSD K.K; Takeda
Research Funding - Chugai Pharma; Lilly Japan; Nihonkayaku; Otsuka; Sanofi; Taiho Pharmaceutical; Takeda